Navigation Links
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Date:7/30/2008

blood. Amyloid plaques, the pathological hallmark of Alzheimer's disease, are composed largely of aggregated amyloid beta proteins. Amyloid plaques or other types of the amyloid beta protein are thought ultimately to disrupt normal nerve cell function in the brain, leading to the dementia that characterizes Alzheimer's disease.

"We are encouraged that in this study, we saw increased amyloid beta which is thought to be bound to LY2062430, in both the blood and cerebrospinal fluid. We hypothesize that this effect may lead to reduced formation of amyloid plaques in the brain after long-term treatment," said Eric Siemers, M.D., Medical Director, Alzheimer's disease research for Eli Lilly and Company. "Alzheimer's disease is complex, and there's a real need for new treatments that might be shown ultimately to slow disease progression. In addition to the biomarker results, we are particularly encouraged by the finding that patients who received the monoclonal antibody treatment over 12 weeks appeared to have no treatment-related side effects."

In this 12-week Phase II study, researchers gave 52 mild to moderate Alzheimer's disease patients infusions of placebo or LY2062430 in varying doses: 100mg or 400mg once a week, or 100mg or 400mg every four weeks. Alzheimer's disease symptom severity was also evaluated. In addition, 16 volunteers each received a single dose of 100mg of LY2062430 or placebo. For all study participants, safety assessments included magnetic resonance imaging (MRI) and cerebrospinal fluid examinations. A sub-study of 24 patients and 13 volunteers underwent single photon emission tomography (SPECT) scanning using an experimental tracer to assess levels of amyloid beta plaque in the brain.

The interim analysis showed that weekly infusions of LY2062430 up to 400mg per dose was well tolerated, with no side effects related to treatment. An evaluation of MRI brain imaging and an assessment of cerebrospinal fluid showed no evidence of brai
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...de study shows the Prox1 gene is a two-way switch ...cells to be reprogrammed so that they lose their i...ls , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-U...esearch Hospital have discovered that a certain di...dentity that it requires the constant expression o...
(Date:12/1/2008)...ISTGARD, Denmark, December 1 /PRNewswire-FirstCall...007 with the intent to procure an MVA-based,thir...vernment Services,Canada, on behalf of the Canadi...contract to Bavarian Nordic for the delivery of IM...d to use IMVAMUNE(R) as part of the,country,s bio...
(Date:12/1/2008)...EGO, Dec. 1 Vical Incorp...pt of a $1.0 million milestone payment from Merck ...n of a Phase I clinical trial of an investigationa... vaccine is based on Vical,s DNA gene delivery tec...criptase (hTERT). hTERT is the subject of separate...
(Date:11/28/2008)...¿RLITZ, Germany, November 28 Germa...leadership in specialized HIV monitoring and,AIDS...emerging countries. In,the year 2008, 2.5 million...ble, robust and highly affordable "CyFlow" system,...ving with HIV/AIDS. Due to introduction of the,Pa...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Cancer Death Rates Stay Stagnant 17443 1Cancer Death Rates Stay Stagnant 17443 2Cancer Death Rates Stay Stagnant 17443 3Crime Scene Investigation methods could help in the battle against hospital infections 17439 1Herbicide tolerant crops can improve water quality 2993 1Herbicide tolerant crops can improve water quality 2993 2United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition 17433 1United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition 17433 2United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition 17433 3United Nations Environment Programme and Bayer Corporation Announce North American Winners of International Childrens Painting Competition 17433 4
... Randomized Safety Program of Intravenous Antihype...ions, NEW ORLEANS, March 27, 2007 /PRNewswire-Firs...ety program comparing intravenous,antihypertensive...ative hypertension -- a potentially harmful elevat...fter surgery - - in,patients undergoing cardiac su...
...EANS--(BUSINESS WIRE)--Mar 26, 2007 - Pfizer annou...Tablets 10 mg provided a,significant 61 percent re... and metabolic syndrome but without heart disease....recurrent stroke or,mini-stroke during the trial h...of major coronary events (death from cardiac cause...
Other Medicine Technology:Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 2Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 3Landmark Findings From ECLIPSE Program Show Improved Control of,Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery 4Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 2Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 3Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 4Lipitor Provides Unprecedented Cardiovascular Risk Reductions in,Diabetes Patients with Metabolic Syndrome and in Stroke Patients 5
(Date:12/1/2008)...GO Including a patient,s photo with imaging exam ...the radiologist interpreting the images, as well a...ng to a study presented today at the annual meetin...NA). , "Our study emphasizes approaching the pa...e study," said lead author Yehonatan N. Turner, M....
(Date:12/1/2008)..., Tenn., Dec. 1 It is a cold Decem...on Vijay Singh, FedExCup Runner-up,Camilo Villega...-- but not to,play golf. The impetus that has br...golf to Memphis is something much more important t... , (Photo: http://www.newscom.com/cgi-bin...
(Date:12/1/2008)...l Sadelain and colleagues, at Memorial Sloan-Kette... approach to modulate the expression of genes for ...ective anticancer therapy in mice. , Small, nonc...atural repressors of gene expression. In the study...pression of genes in immune cells known as T cells...
(Date:12/1/2008)...Walker Chooses Two Tampa Beneficiaries for Par and...TAMPA, Fla., Dec. 1 The...arity of Tampa Bay, Inc. and the Judeo Christian H...the 2009 Par and Poker Celebrity Challenge for Cha..., , "It is only appropriate that events lik...
Breaking Medicine News(10 mins):Health News:Patient photos spur radiologist empathy and eye for detail 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 2Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 3Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 4Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 5Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 6Health News:More than 1,500 Eagles -- Each One with a Story: Eagles Made During PGA TOUR and LPGA Season Result in Record Donation to St. Jude 7Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2
...at the St. Michael's and Toronto General Hospital ...xchange occurred. The scenario was that of two To...ney disease and the other unable to donate one of ...eren't a compatible blood type. Tom McCabe in hi...
... Scotland set out guidelines that through NHS it w... parts of the world. In such places the people are... It was said that they would stop doctors, nurses ...ing the many vacancies in the NHS. They would als...
... Melbourne and La Trobe University have identified...rains such as wheat and barley. With the stress be...earchers fell that this discovery would allow them...s. The genes are important in the production of b...
... “Extreme laziness” which is a medical condition c...is was told by Australian researchers in a report ...l (BMJ) // Professor Leth Argos, a neuroscientist ...edly identified the new disorder. In severe cases ...
Other Medicine News:Health News:Innovative solution to help reduce the waiting times for kidney transplants 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: